Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1993-12-28
|
pubmed:abstractText |
Using in vitro liver systems, we previously demonstrated that 3'-azido-3'-deoxythymidine (AZT) is reduced to a highly toxic metabolite, 3'-amino-3'-deoxythymidine (AMT) through a NADPH-dependent system. This pathway also occurs for other 3'-azido-2',3'-dideoxynucleosides (3'-azido ddNs), indicating that reduction to a 3'-amino metabolite is a general catabolic route of this class of compounds. This study was undertaken to understand the enzymatic reaction responsible for this catabolic pathway. Rat liver microsomes were exposed to 1 mM [3H]AZT or 1 mM [3H]AzddU, and incubated under various conditions. Reduction to the 3'-amino derivative was enhanced 5-fold by the addition of NADPH. When FAD or FMN was combined with NADPH, AMT and AMddU formation was enhanced 2-fold. Addition of equimolar FAD and FMN enhanced azido reducing activity by 3-fold and 5-fold when compared with NADPH alone for AZT and AzddU, respectively. Exposure to carbon monoxide inhibited 3'-amino formation approximately 60%, consistent with involvement of cytochrome P-450 (P-450). This inhibitory effect was not detected in the presence of combined flavin and NADPH; in control incubations that contained these cofactors but no microsomes, AMT or AMddU formation was not observed. This suggests that a flavoprotein, possibly NADPH-cytochrome P-450 reductase (P-450 reductase), is also involved in azido reduction. Preincubation with various P-450 ligands resulted in variable inhibition; reduction of AZT and AzddU was decreased approximately 20-80%.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3'-aminothymidine,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Azides,
http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 Enzyme System,
http://linkedlifedata.com/resource/pubmed/chemical/Dideoxynucleosides,
http://linkedlifedata.com/resource/pubmed/chemical/NADPH-Ferrihemoprotein Reductase,
http://linkedlifedata.com/resource/pubmed/chemical/Phenobarbital,
http://linkedlifedata.com/resource/pubmed/chemical/Zidovudine
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0090-9556
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
946-50
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7902260-Animals,
pubmed-meshheading:7902260-Antibodies,
pubmed-meshheading:7902260-Azides,
pubmed-meshheading:7902260-Cytochrome P-450 Enzyme System,
pubmed-meshheading:7902260-Dideoxynucleosides,
pubmed-meshheading:7902260-Male,
pubmed-meshheading:7902260-Microsomes, Liver,
pubmed-meshheading:7902260-NADPH-Ferrihemoprotein Reductase,
pubmed-meshheading:7902260-Oxidation-Reduction,
pubmed-meshheading:7902260-Phenobarbital,
pubmed-meshheading:7902260-Rats,
pubmed-meshheading:7902260-Rats, Sprague-Dawley,
pubmed-meshheading:7902260-Subcellular Fractions,
pubmed-meshheading:7902260-Time Factors,
pubmed-meshheading:7902260-Zidovudine
|
pubmed:articleTitle |
Reduction of 3'-azido-2',3'-dideoxynucleosides to their 3'-amino metabolite is mediated by cytochrome P-450 and NADPH-cytochrome P-450 reductase in rat liver microsomes.
|
pubmed:affiliation |
Department of Pharmacology, University of Alabama at Birmingham 35294.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|